{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:11:56Z","timestamp":1790687516472,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.humpath.2007.01.028","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T03:39:32Z","timestamp":1179977972000},"page":"1361-1371","source":"Crossref","is-referenced-by-count":219,"title":["Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms"],"prefix":"10.1016","volume":"38","author":[{"given":"Heidi","family":"Kenerson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Folpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond S.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2007.01.028_bib1","series-title":"World Health Organization classification of tumors: pathology and genetics of tumors of soft tissue and bone","first-page":"221","article-title":"Neoplasms with perivascular epitheloid cell differentiation (PEComas)","author":"Folpe","year":"2002"},{"key":"10.1016\/j.humpath.2007.01.028_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2559.2005.02316.x","article-title":"PEComa: what do we know so far?","volume":"48","author":"Hornick","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2007.01.028_bib3","series-title":"Tuberous sclerosis complex","first-page":"10","article-title":"Definition and criteria for diagnosis","author":"Gomez","year":"1999"},{"key":"10.1016\/j.humpath.2007.01.028_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2007.01.028_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4065\/75.6.591","article-title":"High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex","volume":"75","author":"Costello","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.humpath.2007.01.028_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm.164.4.2101154","article-title":"Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex","volume":"164","author":"Moss","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.humpath.2007.01.028_bib7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1164\/ajrccm.162.2.9911006","article-title":"Pulmonary lymphangioleiomyomatosis in a man","volume":"162","author":"Aubry","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.humpath.2007.01.028_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/gcc.2870130411","article-title":"Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas","volume":"13","author":"Henske","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2007.01.028_bib9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1086\/301804","article-title":"Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis","volume":"62","author":"Smolarek","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.humpath.2007.01.028_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00000478-199806000-00003","article-title":"Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study","volume":"22","author":"Martignoni","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2007.01.028_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00000478-200006000-00017","article-title":"Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases: demonstration of the same genetic defects in the primary and metastatic lesions","volume":"24","author":"Martignoni","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2007.01.028_bib12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.humpath.2006.01.008","article-title":"Comparative genomic hybridization study of perivascular epithelioid cell tumor: molecular genetic evidence of perivascular epithelioid cell tumor as a distinctive neoplasm","volume":"37","author":"Pan","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2007.01.028_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2007.01.028_bib14","doi-asserted-by":"crossref","first-page":"15587","DOI":"10.1073\/pnas.95.26.15587","article-title":"The PTEN\/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase\/Akt pathway","volume":"95","author":"Wu","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2007.01.028_bib15","doi-asserted-by":"crossref","first-page":"re15","DOI":"10.1126\/stke.2122003re15","article-title":"TOR signaling","volume":"2003","author":"Harris","year":"2003","journal-title":"Sci STKE"},{"key":"10.1016\/j.humpath.2007.01.028_bib16","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1101\/gad.1199104","article-title":"Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome","volume":"18","author":"Corradetti","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.humpath.2007.01.028_bib17","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2007.01.028_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.molcel.2003.08.016","article-title":"Integration of growth factor and nutrient signaling: implications for cancer biology","volume":"12","author":"Shamji","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.humpath.2007.01.028_bib19","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1101\/gad.1314605","article-title":"Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2","volume":"19","author":"Manning","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.humpath.2007.01.028_bib20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/me.14.6.783","article-title":"A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1","volume":"14","author":"Haruta","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.humpath.2007.01.028_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins","volume":"166","author":"Harrington","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.humpath.2007.01.028_bib22","first-page":"5645","article-title":"Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors","volume":"62","author":"Kenerson","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2007.01.028_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0002-9440(10)62958-6","article-title":"Aberrant beta-catenin signaling in tuberous sclerosis","volume":"167","author":"Mak","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2007.01.028_bib24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.emboj.7600110","article-title":"LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK\/PAR-1","volume":"23","author":"Lizcano","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.humpath.2007.01.028_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","article-title":"Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis","volume":"121","author":"Ma","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2007.01.028_bib26","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/01.pas.0000173232.22117.37","article-title":"Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature","volume":"29","author":"Folpe","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2007.01.028_bib27","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0046-8177(98)90414-2","article-title":"Clonal analysis of renal sporadic angiomyolipomas","volume":"29","author":"Paradis","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2007.01.028_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<79::AID-PATH366>3.0.CO;2-C","article-title":"Molecular analysis of clonality of sporadic angiomyolipoma","volume":"189","author":"Saxena","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2007.01.028_bib29","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00000478-200110000-00002","article-title":"Molecular genetic evidence for different clonal origin of components of human renal angiomyolipomas","volume":"25","author":"Cheng","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2007.01.028_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-4608(88)90263-4","article-title":"Trisomy 7 in a case of angiomyolipoma","volume":"34","author":"de Jong","year":"1988","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2007.01.028_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0165-4608(97)00209-4","article-title":"Chromosome analysis in angiomyolipoma","volume":"99","author":"Dal Cin","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2007.01.028_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0165-4608(96)00267-1","article-title":"Clonal chromosome aberrations in three of five sporadic angiomyolipomas of the kidney","volume":"96","author":"Wullich","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2007.01.028_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0165-4608(95)00035-6","article-title":"Chromosomal abnormalities in non-neoplastic renal tissue","volume":"85","author":"van den Berg","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2007.01.028_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0046-8177(99)90008-4","article-title":"Chromosomal analysis of renal angiomyolipoma by comparative genomic hybridization: evidence for clonal origin","volume":"30","author":"Kattar","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2007.01.028_bib35","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","article-title":"Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma","volume":"361","author":"El-Hashemite","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2007.01.028_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/modpathol.3800624","article-title":"Frequent [corrected] hyperphosphorylation of ribosomal protein S6 [corrected] in lymphangioleiomyomatosis-associated angiomyolipomas","volume":"19","author":"Robb","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2007.01.028_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s004390000348","article-title":"Molecular genetic advances in tuberous sclerosis","volume":"107","author":"Cheadle","year":"2000","journal-title":"Hum Genet"},{"key":"10.1016\/j.humpath.2007.01.028_bib38","first-page":"893","article-title":"Pharmacogenomic profiling of the PI3K\/PTEN-AKT-mTOR pathway in common human tumors","volume":"24","author":"Xu","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.humpath.2007.01.028_bib39","first-page":"38","article-title":"mTOR inhibitors","volume":"4","author":"Cohen","year":"2006","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.humpath.2007.01.028_bib40","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.tp.0000219703.39149.85","article-title":"Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials","volume":"81","author":"Webster","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.humpath.2007.01.028_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1203\/01.PDR.0000147727.78571.07","article-title":"Effects of rapamycin in the Eker rat model of tuberous sclerosis complex","volume":"57","author":"Kenerson","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.humpath.2007.01.028_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/gcc.20118","article-title":"Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models","volume":"42","author":"Lee","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2007.01.028_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/j.seminoncol.2006.06.002","article-title":"Mammalian target of rapamycin inhibitors in renal cell carcinoma: current status and future applications","volume":"33","author":"Pantuck","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.humpath.2007.01.028_bib44","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4161\/cc.4.11.2159","article-title":"mTOR, a new therapeutic target in acute myeloid leukemia","volume":"4","author":"Recher","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2007.01.028_bib45","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1196\/annals.1339.045","article-title":"The role of tuberin in cellular differentiation: are B-Raf and MAPK involved?","volume":"1059","author":"Karbowniczek","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.humpath.2007.01.028_bib46","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1074\/jbc.C200473200","article-title":"The tuberin-hamartin complex negatively regulates beta-catenin signaling activity","volume":"278","author":"Mak","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817707000846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817707000846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T01:56:19Z","timestamp":1546826179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817707000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0046817707000846"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2007.01.028","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}